Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the field of biopharmaceuticals, supplying promising improvements throughout numerous clinical and industrial applications. With its structural similarity to naturally derived human serum albumin, OsrHSA presents a safer, much more reliable alternative for therapeut